Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer
Authors
Keywords
siRNA delivery, Chitosan, Hyaluronic acid dialdehyde, CD44 targeting, Bladder cancer
Journal
Bioactive Materials
Volume 6, Issue 2, Pages 433-446
Publisher
Elsevier BV
Online
2020-09-08
DOI
10.1016/j.bioactmat.2020.08.019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targets for Therapy of Bladder Cancer
- (2020) Christof Seidl SEMINARS IN NUCLEAR MEDICINE
- Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles
- (2019) Eline Oeyen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Predictive biomarkers for drug response in bladder cancer
- (2019) Takahiro Yoshida et al. INTERNATIONAL JOURNAL OF UROLOGY
- CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach
- (2019) Vivek Anand et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- N-Acetyl-Glucosamine Sensitizes Non-Small Cell Lung Cancer Cells to TRAIL-Induced Apoptosis by Activating Death Receptor 5
- (2018) Ye Liang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Bioreduction-ruptured nanogel for switch on/off release of Bcl2 siRNA in breast tumor therapy
- (2018) Huipeng Li et al. JOURNAL OF CONTROLLED RELEASE
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core
- (2018) Takashi Nakamura et al. MOLECULAR PHARMACEUTICS
- Biocompatibility of polymer-based biomaterials and medical devices – regulations, in vitro screening and risk-management
- (2018) Mélisande Bernard et al. Biomaterials Science
- A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro
- (2018) Yujin Chen et al. Cancer Medicine
- Biomacromolecules as carriers in drug delivery and tissue engineering
- (2018) Yujie Zhang et al. Acta Pharmaceutica Sinica B
- Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling
- (2018) Chun-Te Wu et al. ANNALS OF SURGICAL ONCOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chitosan-hyaluronic acid hydrogel for cartilage repair
- (2017) Neethu Mohan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- A hyaluronic acid-based hydrogel enabling CD44-mediated chondrocyte binding and gapmer oligonucleotide release for modulation of gene expression in osteoarthritis
- (2017) Yunpeng Cai et al. JOURNAL OF CONTROLLED RELEASE
- Landmarks in the treatment of muscle-invasive bladder cancer
- (2017) Niyati Lobo et al. Nature Reviews Urology
- Impact of CD44 expression on radiation response for bladder cancer
- (2017) Chun-Te Wu et al. Journal of Cancer
- CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)
- (2016) Darby Oldenburg et al. BMC CANCER
- Precise and efficient siRNA design: a key point in competent gene silencing
- (2016) E Fakhr et al. CANCER GENE THERAPY
- Fabrication, characterization and cytotoxicity studies of ionically cross-linked docetaxel loaded chitosan nanoparticles
- (2016) Ankit Jain et al. CARBOHYDRATE POLYMERS
- Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances
- (2016) Kashappa Goud Desai CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer
- (2016) Li Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Biodistribution and pharmacokinetics ofMad2siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models
- (2016) Ana Vanessa Nascimento et al. Nanomedicine
- Systemic, perioperative management of muscle-invasive bladder cancer and future horizons
- (2016) Samuel A. Funt et al. Nature Reviews Clinical Oncology
- Enhanced Therapeutic siRNA to Tumor Cells by a pH-Sensitive Agmatine–Chitosan Bioconjugate
- (2015) Yongmao Li et al. ACS Applied Materials & Interfaces
- Targeted delivery of CXCR4-siRNA by scFv for HER2+ breast cancer therapy
- (2015) Kuo Jiang et al. BIOMATERIALS
- Increased RIPK4 expression is associated with progression and poor prognosis in cervical squamous cell carcinoma patients
- (2015) De-Qing Liu et al. Scientific Reports
- Ligand-Directed Active Tumor-Targeting Polymeric Nanoparticles for Cancer Chemotherapy
- (2014) Yinan Zhong et al. BIOMACROMOLECULES
- Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier
- (2014) Yijie Chen et al. BIOMATERIALS
- Application of Chitosan-Based Nanocarriers in Tumor-Targeted Drug Delivery
- (2014) Mohammad Ali Ghaz-Jahanian et al. MOLECULAR BIOTECHNOLOGY
- Mad2 Checkpoint Gene Silencing Using Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles in Non-Small Cell Lung Cancer Model
- (2014) Ana Vanessa Nascimento et al. MOLECULAR PHARMACEUTICS
- Hyaluronic acid-coated chitosan nanoparticles: Molecular weight-dependent effects on morphology and hyaluronic acid presentation
- (2013) Abdulaziz Almalik et al. JOURNAL OF CONTROLLED RELEASE
- Insight on the Formation of Chitosan Nanoparticles through Ionotropic Gelation with Tripolyphosphate
- (2012) Emmanuel N. Koukaras et al. MOLECULAR PHARMACEUTICS
- The CD44/integrins interplay and the significance of receptor binding and re-presentation in the uptake of RGD-functionalized hyaluronic acid
- (2011) Sihem Ouasti et al. BIOMATERIALS
- New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine
- (2011) J. B. Shah et al. CLINICAL CANCER RESEARCH
- Frequency of cells expressing CD44, a Head and Neck cancer stem cell marker: Correlation with tumor aggressiveness
- (2011) Benzion Joshua et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Enhanced accumulation of low-molecular-weight chitosan in kidneys: a study on the influence of N-acetylation of chitosan on the renal targeting
- (2011) Zhi-xiang Yuan et al. JOURNAL OF DRUG TARGETING
- Nanocarriers for Cytoplasmic Delivery: Cellular Uptake and Intracellular Fate of Chitosan and Hyaluronic Acid-Coated Chitosan Nanoparticles in a Phagocytic Cell Model
- (2011) Noha M. Zaki et al. MACROMOLECULAR BIOSCIENCE
- An in situ formed biodegradable hydrogel for reconstruction of the corneal endothelium
- (2010) Ye Liang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Fabrication and characters of a corneal endothelial cells scaffold based on chitosan
- (2010) Ye Liang et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for adipose tissue regeneration
- (2010) Huaping Tan et al. Organogenesis
- Delivery of RNA interference therapeutics using polycation-based nanoparticles
- (2009) Kenneth Alan Howard ADVANCED DRUG DELIVERY REVIEWS
- Bcl2 Inhibits Abasic Site Repair by Down-regulating APE1 Endonuclease Activity
- (2008) Jinfeng Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protein adsorption on derivatives of hyaluronic acid and subsequent cellular response
- (2008) Megan S. Lord et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Specific Renal Uptake of Randomly 50%N-Acetylated Low Molecular Weight Chitosan
- (2008) Zhi-xiang Yuan et al. MOLECULAR PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search